Search Results - "D’Silva, Kristin M."

Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases by Cook, Claire, Patel, Naomi J, D'Silva, Kristin M, Hsu, Tiffany Y-T, DiIorio, Michael, Prisco, Lauren, Martin, Lily W, Vanni, Kathleen, Zaccardelli, Alessandra, Todd, Derrick, Sparks, Jeffrey A, Wallace, Zachary Scott

Get more information

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by Gianfrancesco, Milena A., Leykina, Liza A., Izadi, Zara, Taylor, Tiffany, Sparks, Jeffrey A., Harrison, Carly, Trupin, Laura, Rush, Stephanie, Schmajuk, Gabriela, Katz, Patricia, Jacobsohn, Lindsay, Hsu, Tiffany Y., D’Silva, Kristin M., Serling‐Boyd, Naomi, Wallwork, Rachel, Todd, Derrick J., Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S., Liew, Jean W., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Machado, Pedro M., Robinson, Philip C., Yazdany, Jinoos

“…Objective Racial/ethnic minorities experience more severe outcomes of coronavirus disease 2019 (COVID‐19) in the general US population. This study was…”
Get full text

Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series by Dobre, Ioana A., Frank, Angela J., D'Silva, Kristin M., Christiani, David C., Okin, Daniel, Sharma, Amita, Montesi, Sydney B.

“…Immune checkpoint inhibitors (ICIs), such as programmed cell death 1 (PD-1) inhibitors, are used to treat multiple cancers. Limited data exist as to the use of…”
Get full text

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 by Stone, John H, Frigault, Matthew J, Serling-Boyd, Naomi J, Fernandes, Ana D, Harvey, Liam, Foulkes, Andrea S, Horick, Nora K, Healy, Brian C, Shah, Ruta, Bensaci, Ana Maria, Woolley, Ann E, Nikiforow, Sarah, Lin, Nina, Sagar, Manish, Schrager, Harry, Huckins, David S, Axelrod, Matthew, Pincus, Michael D, Fleisher, Jorge, Sacks, Chana A, Dougan, Michael, North, Crystal M, Halvorsen, Yuan-Di, Thurber, Tara K, Dagher, Zeina, Scherer, Allison, Wallwork, Rachel S, Kim, Arthur Y, Schoenfeld, Sara, Sen, Pritha, Neilan, Tomas G, Perugino, Cory A, Unizony, Sebastian H, Collier, Deborah S, Matza, Mark A, Yinh, Janeth M, Bowman, Kathryn A, Meyerowitz, Eric, Zafar, Amna, Drobni, Zsofia D, Bolster, Marcy B, Kohler, Minna, D’Silva, Kristin M, Dau, Jonathan, Lockwood, Megan M, Cubbison, Caroline, Weber, Brittany N, Mansour, Michael K

“…The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for…”
Get full text

COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study by D’Silva, Kristin M., Jorge, April, Cohen, Andrew, McCormick, Natalie, Zhang, Yuqing, Wallace, Zachary S., Choi, Hyon K.

“…Objective Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be concerned about risks of severe coronavirus disease 2019 (COVID‐19)…”
Get full text

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot' by D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Hsu, Tiffany, Fu, Xiaoqing, Gravallese, Ellen M, Choi, Hyon K, Sparks, Jeffrey A, Wallace, Zachary S

“…To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease. We…”
Get more information

COVID-19 and rheumatoid arthritis by D'Silva, Kristin M., Wallace, Zachary S.

“…The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality worldwide. Patients with rheumatoid arthritis (RA) face unique…”
Get full text

Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic by Serling-Boyd, Naomi, D'Silva, Kristin M, Hsu, Tiffany Yt, Wallwork, Rachel, Fu, Xiaoqing, Gravallese, Ellen M, Jorge, April M, Zhang, Yuqing, Choi, Hyon, Sparks, Jeffrey A, Wallace, Zachary S

“…In earlier studies, patients with rheumatic and musculoskeletal disease (RMD) who got infected with COVID-19 had a higher risk of mechanical ventilation than…”
Get more information

SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease by D'Silva, Kristin M, Serling-Boyd, Naomi, Hsu, Tiffany Y-T, Sparks, Jeffrey A, Wallace, Zachary S

Get more information

Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis by D'Silva, Kristin M., Mehta, Raaj, Mitchell, Michael, Lee, Todd C., Singhal, Vibha, Wilson, Marnie Goodwin, McDonald, Emily G.

“…Proton pump inhibitor (PPI) therapy is a potentially modifiable risk factor for recurrent Clostridioides difficile infection (CDI). Citing an absence of…”
Get full text

Hypouricemia and Mortality Risk in the US General Population by D’Silva, Kristin M., Yokose, Chio, Lu, Na, McCormick, Natalie, Lee, Hwajeong, Zhang, Yuqing, Choi, Hyon K.

“…Objective The most recent European Alliance of Associations for Rheumatology (EULAR) recommendations for gout advise against maintaining a serum urate (SU)…”
Get full text

Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C et al by D'Silva, Kristin M, Serling-Boyd, Naomi, Hsu, Tiffany Y-T, Sparks, Jeffrey A, Wallace, Zachary Scott

Get more information

COVID-19 and Disease-Modifying Anti-rheumatic Drugs by D’Silva, Kristin M., Wallace, Zachary S.

“…Purpose of Review Patients on disease-modifying anti-rheumatic drugs (DMARDs) remain concerned about potential risks of severe COVID-19 outcomes. Meanwhile,…”
Get full text

Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020 by Cromer, Sara Jane, D’Silva, Kristin M., Yu, Elaine W., Landon, Joan, Desai, Rishi J., Kim, Seoyoung C.

“…Background New bone-directed therapies, including denosumab, abaloparatide, and romosozumab, emerged during the past decade, and recent trends in use of these…”
Get full text

Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al by D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Hsu, Tiffany, Sparks, Jeffrey A, Wallace, Zachary Scott

Get more information

Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score–Matched Cohort Study by D'Silva, Kristin M, Cromer, Sara Jane, Yu, Elaine W, Fischer, Michael, Kim, Seoyoung C

“…ABSTRACT Zoledronic acid (ZA) is an effective agent in osteoporosis and malignancy‐related bone disease but may be associated with increased risk of atrial…”
Get full text

Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al by D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Hsu, Tiffany Y-T, Sparks, Jeffrey A, Wallace, Zachary Scott

Get more information

Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al by D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Hsu, Tiffany, Sparks, Jeffrey A, Wallace, Zachary S

Get more information

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study by Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D'Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.

“…To describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19…”
Get full text

Increased Risk of COVID‐19 in Patients With Rheumatoid Arthritis: A General Population‐Based Cohort Study by Wang, Yilun, D'Silva, Kristin M., Jorge, April M., Li, Xiaoxiao, Lyv, Houchen, Wei, Jie, Zeng, Chao, Lei, Guanghua, Zhang, Yuqing

“…Objective Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring infections owing to immunologic dysfunction and use of potent…”
Get full text